Study of dosimetric indices and dose constraints to critical organs for head and neck tumours treated with inverse planned simultaneous integrated boost intensity-modulated radiotherapy

Abstract Aim This study aimed to investigate tolerance dose to organs at risk (OARs) as well as degree of conformity and homogeneity for head and neck cancer patients by using simultaneous integrated boost intensity-modulated radiotherapy technique (SIB IMRT). Materials and methods This study analys...

Full description

Saved in:
Bibliographic Details
Published inJournal of radiotherapy in practice Vol. 17; no. 2; pp. 179 - 187
Main Authors Atiq, Atia, Atiq, Maria, Iqbal, Khalid, Shamsi, Qurat-ul-ain, Ahmad Buzdar, Saeed
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aim This study aimed to investigate tolerance dose to organs at risk (OARs) as well as degree of conformity and homogeneity for head and neck cancer patients by using simultaneous integrated boost intensity-modulated radiotherapy technique (SIB IMRT). Materials and methods This study analysed 15 head and neck cancer patients receiving treatment using inverse planned SIB IMRT technique. Using a beam energy of 6 MV, two dose levels of 70 and 55·4 Gy were used to treat the tumour. Doses of 2 Gy in 35 fractions and 1·68 Gy in 33 fractions were simultaneously delivered for effective planning target volume (PTV1) and boost planning target volume (PTV2), respectively. Results Dose distribution in PTV and critical organs lies within tolerance dose guidelines protecting spinal cord, brain stem, optic chiasm, optic nerve, thus reducing the risk of damage to normal tissues. Minor deviation from tolerance limit was observed for parotid glands. This technique provided highly conformal and homogenous dose distribution as well as better sparing of OARs, hence verifying quality assurance results to be satisfactory. Findings SIB IMRT technique offers best solution for preserving organ function by keeping dose below tolerance level. Treatment of head and neck carcinoma using SIB IMRT is feasible, more efficient, and dose escalation is achieved in a single plan.
ISSN:1460-3969
1467-1131
DOI:10.1017/S1460396917000668